Wednesday, 06 July 2022

Takeda receives Arogaya CIBioD Innovation and Enterprise Leadership Award

10 November 2021 | News

The company was recognised for its holistic initiatives designed to improve the quality of life and standards of care for patients

Image credit: Shutterstock

Image credit: Shutterstock

Takeda India has been awarded the Arogaya CIBioD Innovation and Enterprise Leadership Award at the Tech4Seva Summit. The award was received for the company's holistic initiatives designed to improve the quality of life and standards of care for patients, including the 'Blueprint for rare diseases' initiative

 

The awarding body, The Center for Innovation and BioDesign (CIBioD), is an initiative of the Indian Council of Medical Research (ICMR) aimed at promoting research, innovation, and entrepreneurship in the Indian Healthcare System. 

 

Takeda's 'Blueprint for rare diseases' initiative was pioneered together with all the relevant stakeholders in the healthcare value chain, including the Ministry of Health – central and state, patient groups, notified Centre of Excellence, NGOs, and industry bodies. As a part of this initiative, a charter would be developed for stakeholders to commit to improving care and management of Lysosomal Storage Diseases (LSDs) in evolving healthcare systems. It bolsters the nation's commitment towards better health outcomes for collective solution-based innovative approaches and shared responsibilities. 

 

The company has also developed innovative technology-based solutions to improve easy access and coverage to healthcare by connecting healthcare providers and patients.

 

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account